Cenk Sumen

Cenk Sumen

No open positions remaining
53 year
Health Technology
Health Services
Consumer Services

Profile

Cenk Sumen worked as a Director at Thermo Fisher Scientific, Inc. and as a Senior Manager-Business Development at Minaris Regenerative Medicine LLC from 2014 to 2018.
He was also the Chief Scientific Officer at MaxCyte, Inc. from 2022 to 2024.
Currently, he is the Chief Technology Officer at Stemson Therapeutics, LLC.
Dr. Sumen received his undergraduate and doctorate degrees from Stanford University.

Former positions of Cenk Sumen

CompaniesPositionEnd
MAXCYTE, INC. Chief Tech/Sci/R&D Officer 2024-01-22
THERMO FISHER SCIENTIFIC, INC. Director/Board Member 2018-03-31
Corporate Officer/Principal 2018-03-31
Chief Tech/Sci/R&D Officer -
See the detail of Cenk Sumen's experience

Training of Cenk Sumen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!